GNH USA

Europe — EMA

Moxonidin Actavis (Moxonidine)

GNH USA supplies Moxonidin Actavis (Moxonidine), a imidazoline receptor agonist for essential hypertension and resistant hypertension.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidin Actavis, is a imidazoline receptor agonist presented as a tablet for oral use. It treats essential hypertension and other forms of high blood pressure in adults.\n\nGNH India supplies Moxonidin Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidin Actavis is indicated for conditions within the hypertension disease family and works by modulating central sympathetic outflow.\n\nEssential hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.\nResistant hypertension: provides additional blood pressure control when other agents are insufficient.\nHypertension: assists in overall management of elevated systemic arterial pressure.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions that vary in frequency and severity.\n\nCommon Side Effects:\n- Dry mouth\n- Fatigue\n- Dizziness\n- Headache\n- Constipation\n- Nausea\n\nSerious or Rare Side Effects:\n- Severe hypotension\n- Bradycardia\n- Allergic reactions such as rash or angioedema\n- Elevated liver enzymes\n- Depression or mood changes\n- Syncope

What precautions apply to Moxonidine?

When prescribing Moxonidin Actavis, clinicians should consider several safety measures.\n\nMonitor blood pressure: ensure adequate control without excessive drop.\nAdjust dose in renal impairment: reduce dosage if renal function is compromised.\nCaution in diabetes: monitor glucose as sympathetic inhibition may affect glycemic control.\nAvoid abrupt discontinuation: taper to prevent rebound hypertension.\nUse with caution in the elderly: increased sensitivity to hypotensive effects.\nStore at ambient temperature: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidin Actavis can interact with other medicines, requiring attention to potential additive effects.\n\nMajor Interactions (Avoid):\n- Concomitant use with other central antihypertensives (e.g., clonidine) may cause excessive hypotension.\n- Strong CYP2D6 inhibitors may increase plasma levels of moxonidine.\n\nModerate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs) can blunt antihypertensive response.\n- Diuretics may enhance the risk of low blood pressure.\n- Alcohol may increase dizziness and sedation.\n- Lithium therapy may require monitoring for toxicity.

Frequently asked questions

What is Moxonidin Actavis used for?+
Moxonidin Actavis contains the active ingredient moxonidine and is used to lower high blood pressure. It is prescribed for essential hypertension and can be added for patients whose blood pressure remains uncontrolled despite other therapies, including resistant hypertension.
How does moxonidine work?+
Moxonidine acts as a selective agonist at imidazoline I1 receptors in the brainstem. Activation of these receptors reduces sympathetic nervous system outflow, leading to decreased peripheral vascular resistance and heart rate, which together lower arterial blood pressure.
What is the usual dose of Moxonidin Actavis?+
The dose of Moxonidin Actavis is individualized. A qualified prescriber determines the appropriate strength and dosing schedule based on the patient’s blood pressure, renal function, and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.
Is Moxonidin Actavis safe during pregnancy or breastfeeding?+
Limited clinical data are available for moxonidine use in pregnancy and lactation. Because potential risks cannot be ruled out, it is generally not recommended unless the potential benefit justifies the potential risk to the fetus or infant. Consultation with a healthcare provider is essential.
How do I order Moxonidin Actavis from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidin Actavis compare with other antihypertensive drugs?+
Moxonidine belongs to the central imidazoline agonist class, differing from ACE inhibitors, ARBs, calcium‑channel blockers and beta‑blockers that act peripherally. It offers a modest blood‑pressure reduction with a lower incidence of metabolic side effects, but may cause more central nervous system effects such as dry mouth or dizziness.
What are the storage and handling requirements for Moxonidin Actavis?+
Moxonidin Actavis tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date printed on the label.
How is Moxonidin Actavis administered?+
The medication is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber to maintain consistent blood‑pressure control.
What are the most serious risks associated with Moxonidin Actavis?+
Serious adverse events, although uncommon, include severe hypotension, marked bradycardia, allergic reactions such as rash or angioedema, and significant liver‑enzyme elevations. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, or signs of an allergic reaction.
Who should not use Moxonidin Actavis?+
Moxonidin Actavis is contraindicated in patients with known hypersensitivity to moxonidine, severe hypotension, recent myocardial infarction, or those taking other central imidazoline agonists. Caution is also advised for individuals with severe renal impairment or certain cardiac conditions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU